These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32503682)

  • 1. The involving progress of MSCs based therapy in atherosclerosis.
    Lin Y; Zhu W; Chen X
    Stem Cell Res Ther; 2020 Jun; 11(1):216. PubMed ID: 32503682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EndMT-derived mesenchymal stem cells: a new therapeutic target to atherosclerosis treatment.
    Zhang X; Ren Z; Jiang Z
    Mol Cell Biochem; 2023 Apr; 478(4):755-765. PubMed ID: 36083511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Atherosclerosis.
    Ogay V; Sekenova A; Li Y; Issabekova A; Saparov A
    Curr Stem Cell Res Ther; 2021; 16(7):897-913. PubMed ID: 33511957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms underlying the therapeutic potential of mesenchymal stem cells in atherosclerosis.
    Kirwin T; Gomes A; Amin R; Sufi A; Goswami S; Wang B
    Regen Med; 2021 Jul; 16(7):669-682. PubMed ID: 34189963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in mesenchymal stem cells for treatment of atherosclerosis].
    Liu J; Zhang Y; Peng H; Liu P
    Sheng Wu Gong Cheng Xue Bao; 2013 Nov; 29(11):1538-47. PubMed ID: 24701819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells.
    Yang G; Fan X; Liu Y; Jie P; Mazhar M; Liu Y; Dechsupa N; Wang L
    Stem Cell Rev Rep; 2023 Jul; 19(5):1214-1231. PubMed ID: 37058201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
    Kahmini FR; Shahgaldi S
    Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of vascular mesenchymal stem/progenitor cells to hyperlipidemia.
    Chen T; Wu Y; Gu W; Xu Q
    Cell Mol Life Sci; 2018 Nov; 75(22):4079-4091. PubMed ID: 29946805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.
    Wu X; Jiang J; Gu Z; Zhang J; Chen Y; Liu X
    Stem Cell Res Ther; 2020 Aug; 11(1):345. PubMed ID: 32771052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis.
    Li F; Guo X; Chen SY
    Front Cardiovasc Med; 2017; 4():32. PubMed ID: 28589127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice.
    Takafuji Y; Hori M; Mizuno T; Harada-Shiba M
    Cardiovasc Res; 2019 May; 115(6):1041-1051. PubMed ID: 30388208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cells Ameliorate Atherosclerotic Lesions via Restoring Endothelial Function.
    Lin YL; Yet SF; Hsu YT; Wang GJ; Hung SC
    Stem Cells Transl Med; 2015 Jan; 4(1):44-55. PubMed ID: 25504897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro And In vivo Immunomodulating Properties of Mesenchymal Stem Cells.
    Chaudhary D; Trivedi RN; Kathuria A; Goswami TK; Khandia R; Munjal A
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):59-68. PubMed ID: 29485014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cell Therapy for Oral Inflammatory Diseases: Research Progress and Future Perspectives.
    Gong W; Wang F; He Y; Zeng X; Zhang D; Chen Q
    Curr Stem Cell Res Ther; 2021; 16(2):165-174. PubMed ID: 32713335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases.
    Chen X; Wang S; Cao W
    Cell Immunol; 2018 Apr; 326():8-14. PubMed ID: 28778534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
    Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
    Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response.
    Wei X; Sun G; Zhao X; Wu Q; Chen L; Xu Y; Pang X; Qi G
    Int J Mol Med; 2019 Oct; 44(4):1425-1435. PubMed ID: 31364743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells for inflammatory airway disorders: promises and challenges.
    Fan XL; Zhang Z; Ma CY; Fu QL
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.